Treating metastatic cancer with nanotechnology
Metastasis accounts for the vast majority of cancer deaths. The unique challenges for
treating metastases include their small size, high multiplicity and dispersion to diverse organ …
treating metastases include their small size, high multiplicity and dispersion to diverse organ …
Synthesis, functionalization, and design of magnetic nanoparticles for theranostic applications
J Mosayebi, M Kiyasatfar… - Advanced Healthcare …, 2017 - Wiley Online Library
In order to translate nanotechnology into medical practice, magnetic nanoparticles (MNPs)
have been presented as a class of non‐invasive nanomaterials for numerous biomedical …
have been presented as a class of non‐invasive nanomaterials for numerous biomedical …
Cancer theranostics: the rise of targeted magnetic nanoparticles
Interest in utilizing magnetic nanoparticles (MNP) for biomedical applications has increased
considerably over the past two decades. This excitement has been driven in large part by …
considerably over the past two decades. This excitement has been driven in large part by …
Nanomaterials for neural interfaces
This review focuses on the application of nanomaterials for neural interfacing. The junction
between nanotechnology and neural tissues can be particularly worthy of scientific attention …
between nanotechnology and neural tissues can be particularly worthy of scientific attention …
EGFRvIII antibody–conjugated iron oxide nanoparticles for magnetic resonance imaging–guided convection-enhanced delivery and targeted therapy of glioblastoma
CG Hadjipanayis, R Machaidze, M Kaluzova, L Wang… - Cancer research, 2010 - AACR
The magnetic nanoparticle has emerged as a potential multifunctional clinical tool that can
provide cancer cell detection by magnetic resonance imaging (MRI) contrast enhancement …
provide cancer cell detection by magnetic resonance imaging (MRI) contrast enhancement …
Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain
The superparamagnetic properties of magnetic nanoparticles (MNPs) allow them to be
guided by an externally positioned magnet and also provide contrast for MRI. However, their …
guided by an externally positioned magnet and also provide contrast for MRI. However, their …
Magnetic drug targeting: preclinical in vivo studies, mathematical modeling, and extrapolation to humans
KT Al-Jamal, J Bai, JTW Wang, A Protti, P Southern… - Nano …, 2016 - ACS Publications
A sound theoretical rationale for the design of a magnetic nanocarrier capable of magnetic
capture in vivo after intravenous administration could help elucidate the parameters …
capture in vivo after intravenous administration could help elucidate the parameters …
Magnetic Nanoparticle-Based Approaches to Locally Target Therapy and Enhance Tissue Regeneration In Vivo
R Sensenig, Y Sapir, C MacDonald, S Cohen… - …, 2012 - Taylor & Francis
Magnetic-based systems utilizing superparamagnetic nanoparticles and a magnetic field
gradient to exert a force on these particles have been used in a wide range of biomedical …
gradient to exert a force on these particles have been used in a wide range of biomedical …
SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery
CH Fan, CY Ting, HJ Lin, CH Wang, HL Liu, TC Yen… - Biomaterials, 2013 - Elsevier
The blood–brain barrier (BBB) can be temporarily and locally opened by focused ultrasound
(FUS) in the presence of circulating microbubbles (MBs). Currently, contrast-enhanced …
(FUS) in the presence of circulating microbubbles (MBs). Currently, contrast-enhanced …
Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease
E Alphandéry - Nanotoxicology, 2019 - Taylor & Francis
IONP (iron oxide nanoparticles) commercialized for treatments of iron anemia or cancer
diseases can be administered at doses exceeding 1 g per patient, indicating their bio …
diseases can be administered at doses exceeding 1 g per patient, indicating their bio …